Trademark Search in Canada

FLOWER DESIGN FOR ELAGOLIX

View On IC.GC.CA

REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

ABBVIE INC.

1 N. Waukegan RoadNorth Chicago, IL 60064

Serial Number

1831044 filed on 4^th Apr 2017

Registration Number

TMA1027006 registered on 17^th Jun 2019

Registration expiry Date

17^th Jun 2029

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

M5J2T3

FLOWER DESIGN FOR ELAGOLIX

Trademark usage description

pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabete Read More

Vienna Information

3 . 13 . 1

ButterfliesPapillons

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabetes, hypoglycemia, thyroid cancer, glucagonoma, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal diseases and disorders, namely, hormonal imbalance, hyperthyroidism, hypothyroidism, exocrine pancreatic insufficiency (EPI), uterine fibroids and endometriosis

Classification kind code

Mark Details

Serial Number

1831044

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 29^th Mar 2019	Allowed
Submitted for opposition 51 on 29^th Mar 2019	Allowance Notice Sent
Submitted for opposition 42 on 12^th Dec 2018	Advertised
Submitted for opposition 26 on 22^nd Nov 2018	Approved
Submitted for opposition 27 on 5^th Oct 2018	Approval Notice Sent
Submitted for opposition 22 on 6^th Mar 2018	Search Recorded
Submitted for opposition 20 on 6^th Mar 2018	Examiner's First Report
Submitted for opposition 31 on 7^th Apr 2017	Formalized
Submitted for opposition 1 on 5^th Apr 2017	Created
Submitted for opposition 30 on 4^th Apr 2017	Filed